Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans
Authors not listed
VA Office of Research and Development · 2023
Abstract
Frailty is an age-associated clinical condition of poor physiological reserve that increases risks for falls, hospitalization and mortality. Nicotinamide adenine dinucleotide (NAD) is a critical co-factor needed for many cellular processes. The natural levels of NAD decline aging and this has been linked to physical performance decline in animals. Human trials have demonstrated that nicotinamide riboside (NR), a form of vitamin B3, is safe and effectively increases NAD+ levels. In animal studies, NR improves treadmill performance and muscle quality. Here the investigators propose a double-blind randomized control trial to assess the benefits of NR supplementation on human muscle function and physiology. The investigators anticipate the research findings will support the use of this nutritional supplement to improve the health of Veterans during aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2023). Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans. <em>VA Office of Research and Development</em>. https://clinicaltrials.gov/study/NCT04691986
Vancouver
Anonymous. Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans. VA Office of Research and Development. 2023.
BibTeX
@misc{anon2023Impact,
title = {Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans},
author = {Anonymous},
journal = {VA Office of Research and Development},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2022
Open access · CC-BY
Oral nicotinamide riboside raises <scp>NAD</scp>+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin
Molecular Metabolism 2017
Open access · CC-BY
Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells
Nature Communications 2018
Open access · CC-BY
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
bioRxiv (Cold Spring Harbor Laboratory) 2019
Preprint · CC-BY
Nicotinamide riboside augments the human skeletal muscle NAD <sup>+</sup> metabolome and induces transcriptomic and anti-inflammatory signatures in aged subjects: a placebo-controlled, randomized trial
Journal of Clinical Investigation 2024
Open access · CC-BY
Nicotinamide and pyridoxine stimulate muscle stem cell expansion and enhance regenerative capacity during aging
Nutrients 2023
Open access · CC-BY